News
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...
Mitsubishi Tanabe Pharma America’s (MTPA) oral therapy Radicava (edaravone) has shown decreased functional decline and ...
1d
Ansa on MSNItalo-US team in ALS diagnosis breakthrough
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease or Lou Gehrig's Disease, ...
Amyotrophic lateral sclerosis (ALS) is a progressive, disabling, and fatal neurodegenerative disorder that causes muscle weakness, disability, and eventually death. 1 It is most common in adults ...
Amyotrophic Lateral Sclerosis Treatment Market Distribution Channel Insights Hospital pharmacies held a significant revenue share in the amyotrophic lateral sclerosis (ALS) treatment market in ...
More information: C Sahara Khademullah et al, Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis, Brain (2020). DOI: 10.1093/brain/awaa034 ...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease predominantly affecting upper and lower motor neurons. Here, the authors outline previous and current efforts to characterize ...
BOYNTON BEACH, Fla. — Boynton Beach Mayor Ty Penserga proclaimed Sept. 28 as ALS Awareness Day. Amyotrophic lateral sclerosis is a disease that attacks the nervous system, affecting nerve cells ...
Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Annals of Neurology, 2011; 69 (1): 141 DOI: 10.1002/ana.22149 ...
The underlying disease process of amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease), a fatal neurodegenerative disease that paralyzes its victims, has long eluded scientists and ...
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease for which a precise cause has not yet been identified. Standard CT or MRI evaluation does not demonstrate gross structural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results